NCD MedTech Ltd
Investment Round Open

Invest in Africa's NCD future

77% of NCD deaths happen in low- and middle-income countries. Almost none are caught early. We're changing that starting in Rwanda, scaling across the continent.

The Opportunity

A trillion-dollar problem, solved with AI

Non-communicable diseases are the leading cause of death globally yet in Africa, most cases go undetected until it is too late. The infrastructure to change that does not yet exist. We are building it.

Global Market
$15B+

Digital health NCD market by 2028

Target Population
300M+

East Africa addressable population

Rwanda Pilot
300+

Health facilities in initial market

Why Us

Built to win the African digital health market

First-Mover Advantage

No AI-powered, integrated NCD screening platform exists at scale in Sub-Saharan Africa. We are building the category.

Defensible Technology

Proprietary AI models trained on African patient data with a clinical workflow system designed for low-resource settings.

Scalable SaaS Model

B2B/B2G licensing across governments, hospitals, and insurers the same model replicates to every new country at minimal incremental cost.

Mission-Driven Team

Five co-founders with complementary expertise across clinical medicine, AI engineering, finance, and operations.

Business Model

Diversified, recurring revenue

A B2B/B2G SaaS model with multiple revenue streams detailed financial projections available in our investor deck.

Government Contracts
Hospital Subscriptions
Insurance Analytics
Population Health Data
Grants & Development
Corporate Wellness

Where We Are

Early stage. Real progress.

  • AI/ML models in active development for NCD risk scoring
  • Full clinical workflow system designed and prototyped
  • Legally incorporated in Rwanda (RDB)
  • Founding team of 5 experts assembled
  • Concept note and full business plan completed
  • Early engagement with Rwanda Ministry of Health stakeholders

Ready to learn more?

We share our full pitch deck, financial model, and product demo with qualified investors under NDA.

Reach out and we will schedule a call with the founding team.

Reach Out to Us